The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)
Net loss of GW Pharmaceuticals from 2017 to 2020
In 2020, GW Pharmaceuticals reported a net loss of around 58 million U.S. dollars, which is a significant improvement from nearly 300 million U.S. dollars of reported loss in 2018. This statistic illustrates the net loss of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Total revenue of GW Pharmaceuticals 2017-2020
- Basic Statistic Total assets of Jazz Pharmaceuticals 2016-2025
- Premium Statistic Total revenue of Jazz Pharmaceuticals 2016-2025
- Basic Statistic Jazz Pharmaceuticals R&D expenditure 2016-2025
- Basic Statistic Employees at Jazz Pharmaceuticals 2021-2025, by region
- Premium Statistic Medical cannabis market size in the United States 2023-2027
- Premium Statistic Medical cannabis market size forecast by U.S. state 2027
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2022
- Premium Statistic Margin trend in biopharmaceutical industry worldwide 2002-2015
- Premium Statistic Widest CEO-employee pay gap among biopharmaceutical firms 2019
About the region
10
- Premium Statistic Jazz Pharmaceuticals' top product sales 2022-2025
- Premium Statistic Sales forecast of major cannabis pharmaceutical products by world region 2023-2027
- Premium Statistic Sales forecast of major cannabis pharmaceutical products worldwide 2023-2027
- Basic Statistic Cannabis patents under Jazz Pharmaceuticals by patent family 2023
- Basic Statistic Share of cannabis clinical trials worldwide by sponsor 2010-2023
- Premium Statistic Cannabis patents under Jazz Pharmaceuticals' subsidiaries 2023
- Premium Statistic Global vaccine market revenues 2014-2020
- Basic Statistic Value share of biotech sector worldwide by therapeutic area 2021
- Basic Statistic Total revenue of top biopharma companies in gastroenterology 2020
- Premium Statistic Total value biopharma, diagnostics, and medtech M&A deals globally 2008-2020
Selected statistics
10
- Premium Statistic Projected medical cannabis market size in Europe by country 2027
- Premium Statistic Employment at select top pharmaceutical companies in Denmark 2025
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic Value share of pharmaceutical subsectors worldwide 2003 vs. 2021
- Basic Statistic Medical cannabis patients Denmark 2023-2027
- Premium Statistic Medical cannabis market value in Italy 2020-2030, by segment
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2024
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Premium Statistic Medical cannabis market revenue in the United Kingdom 2023-2027
Other regions
10
- Premium Statistic Medical cannabis market size in Europe by country 2023
- Premium Statistic Distribution of medical cannabis oil exports Canada 2020, by importer
- Basic Statistic Quarterly medical cannabis oil products sold in Canada 2016-2019
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Premium Statistic Covid-19 forecast impact on EBITDA margin of pharmaceutical manufacturers Italy 2020
- Premium Statistic Number of prescriptions for cannabinoid-containing medicines in Germany, 2018 to 2024
- Basic Statistic Medical cannabis patients Canada 2023-2027
- Premium Statistic Pharmaceutical R&D expenditure in China 2014-2023
- Premium Statistic Medical cannabis market size forecast New Zealand 2023-2027
Related statistics
10
- Basic Statistic Value of biotech sector worldwide 2021, by therapeutic area
- Basic Statistic Total value of pharmaceutical sector worldwide 2021, by major country
- Basic Statistic Market cap of select biopharma companies worldwide 2011 vs. 2020
- Basic Statistic Total revenue top pharmaceutical companies in CNS care worldwide 2020
- Basic Statistic Top biopharmaceutical companies in cardiometabolic care worldwide 2020
- Basic Statistic Upfront payments by Sanofi in select acquisition and licensing deals 2019-2022
- Basic Statistic Share of pharmaceutical value worldwide 2021, by country
- Basic Statistic Value share of biotech sector worldwide 2021, by country
- Basic Statistic Value share of pharma market worldwide 2015 vs. 2021, by subsector
- Basic Statistic Popular methods of cannabinoid synthesis worldwide 2021
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
GW Pharmaceuticals. (February 26, 2021). Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/
GW Pharmaceuticals. "Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)." Chart. February 26, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/
GW Pharmaceuticals. (2021). Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/
GW Pharmaceuticals. "Net Loss of Gw Pharmaceuticals from 2017 to 2020 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2021, /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/
GW Pharmaceuticals, Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/ (last visited July 29, 2026)
Net loss of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph], GW Pharmaceuticals, February 26, 2021. [Online]. Available: /statistics/1264951/net-loss-of-gw-pharmaceuticals-worldwide/
Advertisement